Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
3.020
+0.110 (3.78%)
At close: Sep 26, 2025, 4:00 PM EDT
2.980
-0.040 (-1.32%)
After-hours: Sep 26, 2025, 7:58 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $16.63 million as of September 26, 2025. Its market cap has increased by 391.07% in one year.
Market Cap
16.63M
Enterprise Value
14.72M
1-Year Change
391.07%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $16.63M, a decrease of -59.62%. That is a compound annual growth rate of -21.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 16.63M | 323.61% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |